Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

545 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Platform trials.
Roustit M, Demarcq O, Laporte S, Barthélémy P, Chassany O, Cucherat M, Demotes J, Diebolt V, Espérou H, Fouret C, Galaup A, Gambotti L, Gourio C, Guérin A, Labruyère C, Paoletti X, Porcher R, Simon T, Varoqueaux N. Roustit M, et al. Among authors: guerin a. Therapie. 2023 Jan-Feb;78(1):29-38. doi: 10.1016/j.therap.2022.12.003. Epub 2022 Dec 5. Therapie. 2023. PMID: 36529559 Free PMC article.
Les essais plateformes.
Roustit M, Demarcq O, Laporte S, Barthélémy P, Chassany O, Cucherat M, Demotes J, Diebolt V, Espérou H, Fouret C, Galaup A, Gambotti L, Gourio C, Guérin A, Labruyère C, Paoletti X, Porcher R, Simon T, Varoqueaux N. Roustit M, et al. Among authors: guerin a. Therapie. 2023 Jan-Feb;78(1):19-28. doi: 10.1016/j.therap.2022.11.011. Epub 2022 Dec 5. Therapie. 2023. PMID: 36581520 Free PMC article. French.
Heterozygous UBR5 variants result in a neurodevelopmental syndrome with developmental delay, autism, and intellectual disability.
Sabeh P, Dumas SA, Maios C, Daghar H, Korzeniowski M, Rousseau J, Lines M, Guerin A, Millichap JJ, Landsverk M, Grebe T, Lindstrom K, Strober J, Ait Mouhoub T, Zweier C, Steinraths M, Hebebrand M, Callewaert B, Abou Jamra R, Kautza-Lucht M, Wegler M, Kruszka P, Kumps C, Banne E, Waberski MB, Dieux A, Raible S, Krantz I, Medne L, Pechter K, Villard L, Guerrini R, Bianchini C, Barba C, Mei D, Blanc X, Kallay C, Ranza E, Yang XR, O'Heir E, Donald KA, Murugasen S, Bruwer Z, Calikoglu M, Mathews JM, Lesieur-Sebellin M, Baujat G, Derive N, Pierson TM, Murrell JR, Shillington A, Ormieres C, Rondeau S, Reis A, Fernandez-Jaen A, Au PYB, Sweetser DA, Briere LC, Couque N, Perrin L, Schymick J, Gueguen P, Lefebvre M, Van Andel M, Juusola J, Antonarakis SE, Parker JA, Burnett BG, Campeau PM. Sabeh P, et al. Among authors: guerin a. Am J Hum Genet. 2025 Jan 2;112(1):75-86. doi: 10.1016/j.ajhg.2024.11.009. Epub 2024 Dec 24. Am J Hum Genet. 2025. PMID: 39721588
Ethics and clinical research: How can the Ethics Committees (CPPs) and Committees for Research Ethics (CER) evolve?
Berdaï D, Guérin A, Pérol D, Girault C, Molimard M, Amiel P, Beaussier H, Bertoye PH, Cornu C, Deplanque D, Dreyfuss D, Duchossoy L, Fouret C, Haaser T, Le Louarn A, Rifai S, Thierry JP. Berdaï D, et al. Among authors: guerin a. Therapie. 2024 Dec 4:S0040-5957(24)00208-7. doi: 10.1016/j.therap.2024.11.006. Online ahead of print. Therapie. 2024. PMID: 39710545
Treatment Effectiveness of Venetoclax-Based Therapy After Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: An International Real-World Study.
Ghosh N, Eyre TA, Brown JR, Lamanna N, Manzoor BS, Coombs CC, Tuncer HH, Ujjani C, Leslie LA, Roeker LE, Davids MS, Rhodes JM, Skarbnik AP, Sinai W, Fleury I, Hill BT, Martinez-Calle N, Barr PM, Jawaid D, Emechebe N, Pearson L, Lansigan F, Choi Y, Jensen CE, Fakhri B, Stephens DM, Marx SE, Schuster SJ, Coyle M, Pivneva I, Watson T, Guerin A, Shadman M. Ghosh N, et al. Among authors: guerin a. Am J Hematol. 2024 Dec 19. doi: 10.1002/ajh.27563. Online ahead of print. Am J Hematol. 2024. PMID: 39698781 No abstract available.
Éthique et recherche clinique : quelles évolutions pour les CPP et les comités d’éthique de la recherche ?
Berdaï D, Guérin A, Pérol D, Girault C, Molimard M, Amiel P, Beaussier H, Bertoye PH, Cornu C, Deplanque D, Dreyfuss D, Duchossoy L, Fouret C, Haaser T, Le Louarn A, Rifai S, Thierry JP. Berdaï D, et al. Among authors: guerin a. Therapie. 2024 Oct 22:S0040-5957(24)00167-7. doi: 10.1016/j.therap.2024.10.051. Online ahead of print. Therapie. 2024. PMID: 39523125 French. No abstract available.
Real-World Evaluation of Treatment Patterns and Clinical Outcomes among Patients With Chronic Myeloid Leukemia in Chronic Phase Treated With Asciminib in Clinical Practice in the United States: Real-world asciminib treatment outcomes in CML-CP.
Atallah EL, Wei D, Latremouille-Viau D, Rossi C, Damon A, Ferreira G, Guérin A, Jadhav K. Atallah EL, et al. Among authors: guerin a. Clin Lymphoma Myeloma Leuk. 2024 Sep 26:S2152-2650(24)02357-7. doi: 10.1016/j.clml.2024.09.013. Online ahead of print. Clin Lymphoma Myeloma Leuk. 2024. PMID: 39426944
Associations between methamphetamine use disorder and SLC18A1, SLC18A2, BDNF, and FAAH gene sequence variants and expression levels.
Guerin AA, Spolding B, Bozaoglu K, Swinton C, Liu Z, Panizzutti Parry B, Truong T, Dean B, Lawrence AJ, Bonomo Y, Nestler EJ, Hamilton PJ, Berk M, Rossell S, Walder K, Kim JH. Guerin AA, et al. Dialogues Clin Neurosci. 2024;26(1):64-76. doi: 10.1080/19585969.2024.2413476. Epub 2024 Oct 12. Dialogues Clin Neurosci. 2024. PMID: 39394974 Free PMC article.
545 results